Donate to Illuminate Contact TSF
Facebook Logo Twitter Logo Youtube Logo Instagram Logo LinkedIn Logo TikTok Logo Blue Sky Logo

El proyecto colectivo humano (HCP) | Español

Virtual: Colombia , Colombia

El Human Collective Project (HCP) es la reunión del grupo de apoyo de TSF que se ofrece a cualquier persona que haya sido afectada/impactada por NMOSD/MOG-AD. El programa nació durante […]

Démarches administratives et handicap

Virtual: France , France

Nous vous invitons à rejoindre notre prochain webinaire le lundi 27 mai à 14h00 CET avec Marie Delenne, Patiente Experte Sclérose en Plaques et ancienne Inspectrice du Travail. Démarches administratives […]

Event Series TSF Patient Day

TSF’s Cleveland Patient Day for NMOSD & MOGAD

Cleveland Clinic Administrative Campus Building 4 3175 Science Park Drive, Beachwood, United States

Are you an NMOSD/MOGAD patient, caregiver, clinician, nurse, researcher and/or advocate in or around Ohio? You're invited to our special day! In collaboration with Dr. Amy Kunchok, Dr. Mary Rensel […]

Approved NMOSD Therapies

Virtual: Global

In 2014, there were 0 FDA-approved therapies for patients living with neuromyelitis optica spectrum disorder (NMOSD). In 2024, there are 4 efficacious, FDA-approved therapies available for patients living with NMOSD. […]

Mi enfermedad ¿Tierra o Sol?

Virtual: Colombia , Colombia

Convivir con un diagnóstico médico puede representar desafíos en diferentes áreas, pero ¿Eso significa necesariamente que se convierte en el sol alrededor del que todos los planos de mi vida […]

Il progetto collettivo umano (HCP) | Italia

Virtual: Italy , Italy

The Human Collective Project (HCP) è l’incontro del gruppo di supporto di TSF offerto a chiunque sia stato colpito/colpito da NMOSD/MOGAD. Il programma è nato durante il culmine della pandemia […]

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.